Prevelance of prostate cancer among Turkish men with prostate-specific antigen level of ?100 ng/ml

Basit Öğe Kaydı
dc.contributor.authorÇalışkan, Selahattin
dc.date.accessioned2019-05-13T08:58:34Z
dc.date.available2019-05-13T08:58:34Z
dc.date.issued2018
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü
dc.description.abstractAim of Study: Prostate cancer (PCa) is one of the most common cancers among men and has become a significant health problem in developing and developed countries. Prostate-specific antigen (PSA) is a useful marker for screening and monitoring the patients. In this study, the author aimed to detect the prevalence of PCa among Turkish patients who underwent prostate biopsy with PSA level of <100 ng/ml. Materials and Methods: The patients who underwent prostate biopsy between January 2008 and January 2015 were reviewed retrospectively. The clinical data that include age, PSA level, and biopsy results were recorded. The patients were divided into five groups according to the PSA levels; ?4, 4.01-10, 10.01-20, 20.01-50, and 50.01-100 ng/ml. Results: There were 1609 patients in this study. Of these patients; 181, 914, 345, 129, and 40 patients had a PSA level of ?4, 4.01-10, 10.01-20, 20.01-50, and 50.01-100 ng/ml, respectively. The patients' ages and PSA levels were between 40 and 89 years with a median of 62 ± 8.32 years and between 0.3 and 100 ng/ml with a median of 7.40 ± 12.97 ng/ml. PCa prevalence increased from 13.25% to 82.5% in the patients with a PSA level of ?4 and 50.01-100 ng/ml. Conclusion: Western populations have more common PCa than Asian men. The studies showed the PCa prevalence for Turkish men was higher than Asian and less than Western origins. Prevalence of PCa was increased with PSA level rising, and this prevalence is between Western and Asian origin similar in the literature. © 2018 Journal of Cancer Research and Therapeutics.
dc.identifier.citationÇalışkan, S. (2018). Prevelance of prostate cancer among Turkish men with prostate-specific antigen level of ?100 ng/ml. Journal of Cancer Research and Therapeutics, 14(6), 1256-1259.
dc.identifier.doi10.4103/0973-1482.187387
dc.identifier.endpage1259en_US
dc.identifier.issn0973-1482
dc.identifier.issue6en_US
dc.identifier.scopusqualityQ3
dc.identifier.startpage1256en_US
dc.identifier.urihttps://doi.org/10.4103/0973-1482.187387
dc.identifier.urihttps://hdl.handle.net/11491/1161
dc.identifier.volume14en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.relation.ispartofJournal of Cancer Research and Therapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBiopsyen_US
dc.subjectPrevalenceen_US
dc.subjectProstate Canceren_US
dc.subjectProstate Specific Antigenen_US
dc.titlePrevelance of prostate cancer among Turkish men with prostate-specific antigen level of ?100 ng/ml
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
scaliskanson.pdf
Boyut:
517.28 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu